search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Detection of lung cancer from exhaled air with e-Nose


- candidate number21951
- NTR NumberNTR5175
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR15-apr-2015
- Secondary IDsK15-17 METC Twente
- Public TitleDetection of lung cancer from exhaled air with e-Nose
- Scientific TitleDetection of lung cancer from exhaled air with e-Nose
- ACRONYM
- hypothesisCan the eNose detect VOC patterns that distinguish between patients with and without lung cancer?
- Healt Condition(s) or Problem(s) studiedLung cancer
- Inclusion criteriaSubjects suspected for lung cancer:
1. Scheduled to undergo CT-scanning;
2. They have suspicion of lung cancer based on the one or more of the following points:
a. Respiratory symptoms such as: haemoptysis, coughing, dyspnoea;
b. General symptoms that go with malignancy, such as: weight loss, nocturnal hyperhidrosis, fever, and/or loss of appetite;
c. An anomalous chest X-ray;
3. Age ≥ 40 years;
4. Smoker or ex-smoker.

Healthy subjects:
1. A negative history of chest symptoms, for example asthma, COPD, other respiratory conditions.
- Exclusion criteriaSubjects suspected for lung cancer:
1. Subjects with other prior known malignancies;
2. Subjects with a history of upper or lower respiratory tract infection during the past 4 weeks prior to measurements which required pharmacological treatment with antibiotics or systemic corticosteroids.

Healthy subjects:
1. Subjects with known significant metabolic disease, such as: diabetes mellitus, liver failure or active liver disease, renal failure, haemodialysis or cardiac failure, because of possible (un)known effects on metabolism;
2. Subjects with known COPD;
3. Subjects with an underlying malignancy.
- mec approval receivedyes
- multicenter trialyes
- randomisedno
- groupParallel
- Type2 or more arms, non-randomized
- Studytypeobservational
- planned startdate 1-mei-2015
- planned closingdate1-mei-2016
- Target number of participants300
- InterventionsMeasurement of exhaled breath with an electronic nose.
- Primary outcomeDetection of differences in patterns of exhaled breath in patients diagnosed with lung cancer from subjects with a rejected diagnosis of lung cancer and healthy subjects.
- Secondary outcome- Detection of different patterns of exhaled breath in different lung cancer stages.
- Detection of different patterns of exhaled breath in different types of lung cancer.
- TimepointsLung cancer: yes or no. 1 measurement
Type of lung cancer: NSCLC or SCLC. 1 measurement
Stadium of lung cancer: TNM classification and staging. 1 measurement.
- Trial web site
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIES Sharina Kort
- CONTACT for SCIENTIFIC QUERIES Sharina Kort
- Sponsor/Initiator Medisch Spectrum Twente
- Funding
(Source(s) of Monetary or Material Support)
The eNose Company
- Publications
- Brief summaryThere is not yet a quick test, nor a non-invasive method to identify subjects with lung cancer. The Aeonoseô (electronic nose) is a diagnostic test device to detect patterns of volatile organic compounds (VOCís) in exhaled air. These VOCís are related to metabolic activities in the body. It is assumed that the disease-specific metabolic pathways may give rise to specific VOC patterns and therefore aid in the diagnostic process. Pilot studies have already indicated that electronic noses, consisting of an array of VOC-sensors, may be used to detect diseases in different diagnostic areas, including malignancies. The aim of this study is to investigate whether the eNose can detect VOC patterns that distinguish between patients suspected for lung cancer with a confirmed histopathological diagnosis and patients suspected for lung cancer with a rejected diagnosis of lung cancer. Also, we want to compare VOC patterns of those with a confirmed diagnosis of lung cancer with healthy subjects without any suspicion for lung cancer.
- Main changes (audit trail)
- RECORD15-apr-2015 - 5-jul-2015


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl